Saad J. Kenderian, M.B., Ch.B.

The Gastrointestinal (GI) Cancer Program at Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota, offers hope through our expert teams of specialized doctors who provide accurate diagnoses and offer the latest treatment options for esophageal cancer, stomach cancer, colorectal cancer, anal cancer and gastrointestinal cancers that have metastasized. You will have access to the full range of cancer treatments, including minimally invasive surgeries, robotic and laparoscopic, endoscopic mucosal resection, esophagectomy, complex esophageal reconstruction, gastrectomy, hyperthermic intraperitoneal chemotherapy (HIPEC), targeted radiation treatments such as proton beam therapy, immunotherapies and cutting-edge clinical trials. Mayo Clinic’s Gastrointestinal Neoplasia Clinic specializes in the prevention, early detection, diagnostic evaluation and integrated management of luminal gastrointestinal pre-cancers and cancers for people at higher-than-average risk of stomach and colorectal cancer based on family history, personal history or having other gastrointestinal diseases like Crohn’s or ulcerative colitis. Mayo Clinic is top-ranked in more specialties than any other hospital, according to U.S. News & World Report, and the Cancer Center continually ranks among the top hospitals in the U.S. for cancer. Mayo Clinic Comprehensive Cancer Center is a National Cancer Institute (NCI)-designated comprehensive cancer center.

Dr. Rahma Warsame is an associate professor of medicine and oncology at the Mayo Clinic College of Medicine and Science, specializing in hematology with a focus on plasma cell disorders, particularly amyloidosis. With over 60 peer-reviewed publications and numerous awards, she is dedicated to advancing patient care through research and education. In addition to her clinical practice, Dr. Warsame actively mentors medical students, residents, and fellows, serving as the associate program director of the internal medicine residency program. Her research interests include patient-reported outcomes, quality of life, and healthcare costs, reflecting her commitment to improving patient experiences in the field of hematology. Generated from the website

Dr. Naseema Gangat, M.B.B.S., is a distinguished hematologist and oncologist at Mayo Clinic in Rochester, Minnesota, where she serves as a professor of medicine and consultant in hematology. With extensive training and board certifications in medical oncology, internal medicine, and hematology, she has made significant contributions to the field through her clinical research and educational initiatives. Dr. Gangat specializes in myeloid malignancies, particularly myelodysplastic syndromes and myeloproliferative neoplasms, and has published over 100 peer-reviewed articles. Her commitment to excellence in teaching has earned her multiple awards, including the Hematology Oncology Fellowship Teacher of the Year at Mayo Clinic. Generated from the website